We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · October 11, 2021

More Intravitreal Anti–VEGF Injections Are Associated With Mild Cognitive Impairment

Retina (Philadelphia, Pa.)

 

Additional Info

Retina (Philadelphia, Pa.)
BRAIN HEALTH ASSESSMENT IN MACULAR DEGENERATION PATIENTS UNDERGOING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS (THE BHAM STUDY): An Interim Analysis
Retina (Philadelphia, Pa.) 2021 Aug 01;41(8)1748-1753, SK Ray, SN Manz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading